Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.320
-0.180 (-4.00%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 869 employees as of December 31, 2024. The number of employees increased by 7 or 0.81% compared to the previous year.
Employees
869
Change (1Y)
7
Growth (1Y)
0.81%
Revenue / Employee
$554,710
Profits / Employee
-$1,078
Market Cap
547.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ORGO News
- 4 weeks ago - Organogenesis Holdings Inc. (ORGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire
- 4 months ago - Organogenesis Expands Manufacturing Capacity to Support Future Growth - GlobeNewsWire
- 4 months ago - Organogenesis Commends Final LCDs - GlobeNewsWire
- 4 months ago - Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - GlobeNewsWire
- 5 months ago - Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis - GlobeNewsWire